+1 7178835943 [email protected]
Hybrid Event (In-person or Virtual participation)

International Conference on Interventional Oncology · Registering as Listener

ICIO
📅 11 – 12 Feb 2027 📍 Birgu, Malta 👥 Standard / Physical Participation
Listener Registration From
$165
Registration Benefits:
Official invitation letterIssued automatically after registration
🎖 Certificate & digital materialsGet certificate, slides and resource materials
🌐 Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon Code (If Any)

Have a code? Apply it here — the discount updates the total immediately.

🏷

For Support Please Contact

VISAMASTERCARDNET BANKINGUPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceInternational Conference on Interventional Oncology
ModeStandard / Physical
ParticipationListener
Registration fee$165.00
Bank charges (5.8%)$9.57
Total payable $174.57

Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

📞 +91 93445 35349

Benefits of Registering as Listener

👥Access to Conference Sessions
🔗Networking Opportunities
🎖Certificate of Participation
Invitation Letter Support
📚Conference Kit / Materials
🎤Access to Keynote Sessions
• Conference Session Tracks •
SDG

SDG-Aligned Research Themes

Conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 SDG 4 SDG 9 SDG 10

This track will explore the latest research and clinical practices in the diagnosis and treatment of breast cancer patients. Emphasis will be placed on innovative therapeutic approaches, including targeted therapies and immunotherapy.

This session will focus on the integration of cardiovascular and interventional radiology techniques in the management of cancer patients. Discussions will include the impact of these interventions on patient outcomes and complication management.

This track will examine the role of chemotherapeutic drugs in the treatment of various cancers, highlighting both their effectiveness and the challenges faced in clinical settings. Special attention will be given to resistance mechanisms and strategies to overcome them.

This session will delve into the latest advancements in the diagnosis and treatment of colorectal cancer patients. Topics will include novel therapeutic agents, surgical techniques, and the management of CRC metastases.

This track will discuss the role of genomics in cancer diagnosis and treatment, emphasizing personalized medicine approaches. Participants will explore how genomic data can inform therapeutic decisions and improve patient outcomes.

This session will focus on the latest developments in immunotherapy for cancer, including checkpoint inhibitors and CAR T-cell therapy. The discussion will cover clinical trial results and real-world applications.

This track will highlight minimally invasive procedures performed under image guidance, including tumor ablation techniques such as radiofrequency ablation. The focus will be on patient safety, efficacy, and recovery.

This session will address the morbidity and mortality associated with various cancer treatments and interventions. Participants will discuss strategies to mitigate risks and improve quality of life for cancer patients.

This track will explore the latest approaches in the diagnosis and treatment of kidney tumors, including surgical and non-surgical options. Emphasis will be placed on patient selection and outcomes.

This session will focus on the diagnosis and treatment of lung tumors and metastases, discussing both conventional and novel therapeutic strategies. Participants will explore the impact of early detection on treatment success.

This track will examine the management of musculoskeletal tumors through interventional techniques, including biopsy and ablation. The discussion will highlight the importance of a multidisciplinary approach in optimizing patient care.

COPYRIGHT © 2026 ISAR. ALL RIGHTS RESERVED